ID28291A - Agonis reseptor 5hti dan metoklopramida untuk penyembuhan migren - Google Patents

Agonis reseptor 5hti dan metoklopramida untuk penyembuhan migren

Info

Publication number
ID28291A
ID28291A IDW00200100930A ID20010930A ID28291A ID 28291 A ID28291 A ID 28291A ID W00200100930 A IDW00200100930 A ID W00200100930A ID 20010930 A ID20010930 A ID 20010930A ID 28291 A ID28291 A ID 28291A
Authority
ID
Indonesia
Prior art keywords
migren
methoclopramides
healing
receptor agonists
5hti
Prior art date
Application number
IDW00200100930A
Other languages
English (en)
Indonesian (id)
Inventor
George Harry Sands
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID28291A publication Critical patent/ID28291A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW00200100930A 1998-10-30 1999-10-18 Agonis reseptor 5hti dan metoklopramida untuk penyembuhan migren ID28291A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10632898P 1998-10-30 1998-10-30

Publications (1)

Publication Number Publication Date
ID28291A true ID28291A (id) 2001-05-10

Family

ID=22310818

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200100930A ID28291A (id) 1998-10-30 1999-10-18 Agonis reseptor 5hti dan metoklopramida untuk penyembuhan migren

Country Status (34)

Country Link
US (2) US6255334B1 (ko)
EP (1) EP1126840A1 (ko)
JP (1) JP2002528497A (ko)
KR (1) KR20010089363A (ko)
CN (1) CN1325304A (ko)
AP (1) AP2001002129A0 (ko)
AR (1) AR019246A1 (ko)
AU (1) AU5994799A (ko)
BG (1) BG105534A (ko)
BR (1) BR9914901A (ko)
CA (1) CA2348543A1 (ko)
CO (1) CO4950530A1 (ko)
CZ (1) CZ20011468A3 (ko)
EA (1) EA200100284A1 (ko)
EE (1) EE200100243A (ko)
GT (1) GT199900189A (ko)
HK (1) HK1040929A1 (ko)
HR (1) HRP20010298A2 (ko)
HU (1) HUP0104696A3 (ko)
ID (1) ID28291A (ko)
IL (1) IL141957A0 (ko)
IS (1) IS5898A (ko)
MA (1) MA26702A1 (ko)
NO (1) NO20012013D0 (ko)
OA (1) OA11669A (ko)
PA (1) PA8484801A1 (ko)
PE (1) PE20001284A1 (ko)
PL (1) PL347541A1 (ko)
SK (1) SK5522001A3 (ko)
TN (1) TNSN99203A1 (ko)
TR (1) TR200101174T2 (ko)
TW (1) TW524692B (ko)
WO (1) WO2000025778A1 (ko)
ZA (1) ZA200103322B (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0105131D0 (en) * 2001-03-01 2001-04-18 Pfizer Ltd Compositions having improved bioavailability
US6579898B2 (en) * 2001-03-01 2003-06-17 Pfizer Inc. Compositions having improved bioavailability
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
WO2002094218A2 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US6759029B2 (en) * 2001-05-24 2004-07-06 Alexza Molecular Delivery Corporation Delivery of rizatriptan and zolmitriptan through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US6805853B2 (en) * 2001-11-09 2004-10-19 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
AU2002363947A1 (en) 2001-11-21 2003-07-24 Alexza Molecular Delivery Corporation Delivery of caffeine through an inhalation route
EP1503744A1 (en) 2002-05-13 2005-02-09 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
CA2507159A1 (en) 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
CA2526475A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
CA2569964A1 (en) * 2004-06-10 2005-12-29 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
US20050282879A1 (en) * 2004-06-17 2005-12-22 Foad Salehani Methods and composition for treatment of migraine and symptoms thereof
US7375219B2 (en) 2005-04-13 2008-05-20 Neuraxon, Inc. Substituted indole compounds having NOS inhibitory activity
AR060451A1 (es) * 2006-04-13 2008-06-18 Neuraxon Inc Compuestos de indol 1,5 y 3,6-sustituidos con actividad inhibitoria de nos
US20080139510A1 (en) * 2006-12-07 2008-06-12 Abe Rose Treatment of migraine headaches with sublingual amino acids
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
CA2705422A1 (en) * 2007-11-16 2009-05-22 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for treating visceral pain
US20090131503A1 (en) * 2007-11-16 2009-05-21 Annedi Subhash C 3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
EA201000808A1 (ru) * 2007-11-16 2011-04-29 Ньюраксон, Инк. Индольные соединения и способы лечения висцеральной боли
AU2013202680C1 (en) * 2008-04-28 2016-06-23 Zogenix, Inc. Novel formulations for treatment of migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
IL127956A0 (en) * 1996-07-11 1999-11-30 Farmarc Nederland Bv Inclusion complex containing indole selective serotonin agonist
GB9709739D0 (en) 1997-05-14 1997-07-02 Merck Sharp & Dohme Pharmaceutical formulation

Also Published As

Publication number Publication date
OA11669A (en) 2005-01-05
AU5994799A (en) 2000-05-22
TNSN99203A1 (fr) 2005-11-10
EP1126840A1 (en) 2001-08-29
AP2001002129A0 (en) 2001-06-30
JP2002528497A (ja) 2002-09-03
PA8484801A1 (es) 2000-09-29
ZA200103322B (en) 2002-06-10
HRP20010298A2 (en) 2002-06-30
CN1325304A (zh) 2001-12-05
NO20012013L (no) 2001-04-24
SK5522001A3 (en) 2002-05-09
US6255334B1 (en) 2001-07-03
WO2000025778A1 (en) 2000-05-11
IL141957A0 (en) 2002-03-10
AR019246A1 (es) 2001-12-26
CZ20011468A3 (cs) 2002-04-17
GT199900189A (es) 2001-04-21
TW524692B (en) 2003-03-21
EA200100284A1 (ru) 2001-10-22
TR200101174T2 (tr) 2001-10-22
US20010020036A1 (en) 2001-09-06
IS5898A (is) 2001-03-16
CO4950530A1 (es) 2000-09-01
CA2348543A1 (en) 2000-05-11
HUP0104696A3 (en) 2003-05-28
HK1040929A1 (zh) 2002-06-28
EE200100243A (et) 2002-12-16
PL347541A1 (en) 2002-04-08
PE20001284A1 (es) 2000-11-22
MA26702A1 (fr) 2004-12-20
BR9914901A (pt) 2001-07-17
BG105534A (en) 2001-12-29
KR20010089363A (ko) 2001-10-06
NO20012013D0 (no) 2001-04-24
HUP0104696A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
ID28291A (id) Agonis reseptor 5hti dan metoklopramida untuk penyembuhan migren
ID17182A (id) Adrenergis b3 agonis pilihan
DE69814714D1 (de) Zentriervorrichtung für Femurimplantat
DE69819567D1 (de) Orthopädische Schnittführung und Hülse
DE69939803D1 (de) Multifunktionales Gerät für Chirurgie
ID29013A (id) Ligan-ligan reseptor novel thiroid dan metode ii
ID24836A (id) Agonis prostaglandin
ATE384484T1 (de) Einstufiges implantatsystem
ATE263116T1 (de) Ankoppelvorrichtung und flaschen
DE59913885D1 (de) Knochenfixationsvorrichtung mit drehgelenk
DE69732184D1 (de) Futter
DE69803666D1 (de) Beleuchtungsvorrichtung
DE69716153D1 (de) Beleuchtungsgerät
ATE223911T1 (de) Benzothiophenecarboxamid-derivate und diese enthaltende pgd2 antagonisten
ID26639A (id) Sediaan farmasi yang mengandung agonis reseptor angiotensin ii jenis 2 dan pemakaiannya
ID27544A (id) Agonis dan antagonis muskarinat
DE69826837D1 (de) Inspektionsverfahren
DE69506826D1 (de) 5-HT4 Rezeptoragonisten
DE69817095D1 (de) Propylenpolymer-zusammensetzung und unter wärme geformter gegenstand
ID22060A (id) Senyawa-senyawa 2-imidazolinilaminobenzoksazol berguna sebagai agonis adrenoseptor
NO963331D0 (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DE69729540D1 (de) Schmelzbehandlungsvorrichtung
DE69940718D1 (de) Beleuchtungsvorrichtung und Projektionsvorrichtung
NO993279D0 (no) Absorberende interlabial anordning med foldet struktur
FI991137A (fi) Laite ja järjestely oftalmoskopiaa varten